Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 68788-8360 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Schematic, timelineDescription automatically generated - E8E272A4 C181 4573 822B 2BB315B6AD37 00
![E8E272A4-C181-4573-822B-2BB315B6AD37-00.jpg Schematic, timelineDescription automatically generated - E8E272A4 C181 4573 822B 2BB315B6AD37 00](https://ndclist.com/assets/spl/images/e8e272a4-c181-4573-822b-2bb315b6ad37/400x-E8E272A4-C181-4573-822B-2BB315B6AD37-00.jpg)
This is a pharmaceutical label for Pregabalin Capsules 100mg, a generic drug for Lyrica. It warns that federal law prohibits the transfer of this medication to any person other than the patient for whom it was prescribed. It also lists the manufacturer (Ascend Laboratories, LLC) and expiration date, production and batch numbers, and quantity. A billing chart log for the patient is also mentioned.*
pregabalin-Figure-6 - pregabalin figure 6
![pregabalin-figure-6.jpg pregabalin-Figure-6 - pregabalin figure 6](https://ndclist.com/assets/spl/images/e8e272a4-c181-4573-822b-2bb315b6ad37/400x-pregabalin-figure-6.jpg)
This appears to be a table summarizing the results of multiple studies evaluating the effectiveness of different doses of an unidentified medication compared to a placebo. The medication was studied in at least three different trials (E1, E3, and one not named) at doses ranging from 50mg/day to 600mg/day. The table reports the percentage change in some outcome variable (not specified) for each dose level, as well as the percentage change in the placebo group. One dose level (not specified) had a statistically significant effect compared to placebo.*
Fibromyalgia Study F1 - pregabalin image 8
![pregabalin-image-8.jpg Fibromyalgia Study F1 - pregabalin image 8](https://ndclist.com/assets/spl/images/e8e272a4-c181-4573-822b-2bb315b6ad37/400x-pregabalin-image-8.jpg)
This appears to be a chart showing the percentage of patients who experienced improvement in pain from baseline after taking different doses of Pregabalin. The chart displays percentages ranging from 0% to 100%, with the largest percentage of patients experiencing improvement after taking a daily dose of 600mg.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.